Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
UK set on resolving standoff with big pharma, science minister says
The UK is “determined to solve” its standoff with the pharmaceutical industry and reverse a 10-year decline in NHS spending on medicines, the science minister has told MPs, after a string of drugmakers cancelled projects worth nearly…
FDA-After Trump Order-Warns Pharma Giants Over Weight-Loss Ads
The Food and Drug Administration sent warning letters to dozens of drug companies— including popular telehealth firm Hims & Hers and pharmaceutical giants Eli Lilly and Novo Nordisk— demanding they correct “false or misleading…
Pharma stocks slide as US headwinds hurt
Concerns over weakening demand for Indian pharmaceutical (pharma) drugs in the US — their largest export market — have weighed heavily on investor sentiment this year. While the Nifty 50 has gained 6.02 per cent year - to - date (as…
Nxera Pharma and Cancer Research UK Announce First Patient Dosed in Phase 2a Trial of Investigational Cancer Immunotherapy HTL0039732
HTL0039732 (also known as NXE0039732) is Nxera's novel oral EP4 antagonist being investigated to treat a wide range of solid cancers in combination with other immunotherapies Cancer Research UK's Centre for Drug Development is sponsoring and…
Italfarmaco Announces Exclusive Distribution Agreement with Multicare Pharma for DMD Treatment Givinostat in Brazil
Italfarmaco has entered into an agreement with Multicare for the regulatory approval and distribution of givinostat as a treatment for Duchenne muscular dystrophy in Brazil. MILAN, Italy, and SÃO PAULO, Brazil, September 16, 2025 –…
Who benefits if NHS drug prices soar? Donald Trump and big pharma. Just one more way he's menacing Britain | Polly Toynbee
Governing in the era of Donald Trump has been Labour's miserable misfortune. As our prime minister and king grovel to the global bully with royal folderol this week, we will probably feel the full humiliation of the would-be American king. The…
Eli lilly to invest $5 billion in new Virginia plant as pharma braces for tariffs
(Reuters) -Eli Lilly said on Tuesday it will invest $5 billion to build a manufacturing facility in Virginia, the first of four new U.S. plants the drugmaker has planned as it moves to expand domestic production and hedge against potential tariffs.
Pharma firms pile pressure on the UK as Trump's drug pricing order looms
Pharma firms are facing pressure from the Trump administration over drug pricing. Several global pharma firms have pulled or paused U.K. investments amid waning government support for the sector. Merck, AstraZeneca and Eli Lilly are among those…
GSK plans $30 billion US investment as pharma tariff threat looms
GSK said on Wednesday it plans to invest $30 billion in research and development and supply chain infrastructure in the United States over the next five years, after US President Donald Trump arrived in Britain for an unprecedented second state…
Eli Lilly to invest $5B on Virginia plant amid Trump's pharma tariff threats
Eli Lilly on Tuesday announced a $5 billion investment in a manufacturing facility in Virginia as the pharmaceutical giant looks to expand its domestic production capacity amid the threat of tariffs. The manufacturing facility is expected to…
How Do Investors Really Feel About Royalty Pharma? - Royalty Pharma (NASDAQ:RPRX)
Royalty Pharma's short interest as a percent of float has risen 18.13% since its last report. According to exchange reported data, there are now 16.62 million shares sold short, which is 3.91% of all regular shares that are available for trading.
Scheme to promote innovation in pharma, medtech sectors to be launched this month: Pharma Secy
The government is looking to formally launch a scheme to promote innovation in the pharmaceutical and medtech sectors within this month, Department of Pharmaceuticals Secretary Amit Agrawal said on Tuesday. The Promotion of Research and Innovation…
GSK plots $30bn investment into US in blow to UK pharma sector
GSK has become the latest pharma giant to direct investment away from the UK as it unveiled a new plan to spend $30bn (£22bn) on research and manufacturing facilities in the US. The London-based business said the capital would be deployed…
Piramal Pharma Solutions Augments Formulation Capabilities with the Addition of New Korsch XM-12 Bilayer Tablet Press at its Morpeth, UK Facility
With the strategic addition of the Korsch XM-12 bilayer tablet press, the Formulation Development Team at Morpeth can now achieve high tablet output across flexible formats with greater precision and efficiency. The XM-12 is designed for both…
What to know about Trump's proposed crackdown on DTC pharma ads
The Trump administration's proposed crackdown on direct-to-consumer pharma ads understandably caught the attention of industry stakeholders who spent months awaiting such action. Both President Donald Trump as well as Health and Human Services…
Receive a Daily briefing on Pharma Industry News
Get Started